Heng Fai Ambrose Chan - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 3, 2026
Heng Fai Ambrose Chan has filed 2 SEC Form 4 filings across 2 companies in the last 90 days - active on both sides. Lifetime open-market purchases: $5.13M. Lifetime open-market sales: $5.82M. Historical track record: 2/5 stars across 6 tracked purchases.
Profile
Heng Fai Ambrose Chan holds the role of Director at DSS, INC. (DSS). Chan's filing history also covers HWH International Inc. (HWH) and SHARING SERVICES GLOBAL Corp (SHRG). Chan has reported 26 insider filings with the SEC since 2024. The most recent filing was in July 2026.
| Role | Director, 10% Owner |
|---|---|
| Notability | 55/100 |
Board memberships
- DSS, INC.
- HWH International Inc.
- SHARING SERVICES GLOBAL Corp
- Alset Inc.
- IMPACT BIOMEDICAL INC.
Reported roles
- Director
- Chief Executive Officer
- 10% Owner
- Chief Executive Officer
- Director
Awards & honors
- Leadership in multiple public companies
- Significant ownership stakes in various firms
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★☆☆☆ (2/5) |
|---|---|
| Total purchases tracked | 6 |
| Purchases with forward-return data | 6 |
| 30-day win rate | 17% |
| 90-day win rate | 17% |
| Avg 5-day return | +14.02% |
| Avg 30-day return | +11.29% |
| Avg 90-day return | -6.87% |
| Best 30-day return | +137.31% |
Trading Pattern
InsiderAlpha's records for Heng Fai Ambrose Chan go back to 2024: 23 primary Form 4 filings, an average of 7.7 per year. The typical open-market purchase is $342K (15 buys totaling $5.13M). The largest single buy on record is $3.00M of HWH in 2024. Sales side: 15 recorded sales totaling $5.82M, so the filing history runs sell-heavy by dollar value. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role Heng Fai Ambrose Chan has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Director, 10% Owner at DSS, INC. (DSS) - 4 filings, 2024 to 2026
- Chief Executive Officer, Director, 10% Owner at HWH International Inc. (HWH) - 3 filings, 2025 to 2026
- 10% Owner at SHARING SERVICES GLOBAL Corp (SHRG) - 4 filings, 2025 to 2026
- Chief Executive Officer, Director, 10% Owner at Alset Inc. (AEI) - 5 filings, 2025
- Director at IMPACT BIOMEDICAL INC. (IBO) - 1 filing, 2025
- Director, 10% Owner at IMPACT BIOMEDICAL INC. (IBO) - 2 filings, 2025
- Director, 10% Owner at SHARING SERVICES GLOBAL Corp (SHRG) - 1 filing, 2025
- Director, 10% Owner at Value Exchange International, Inc. (VEII) - 1 filing, 2025
- Director, 10% Owner at HWH International Inc. (HWH) - 2 filings, 2024
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-09 | HWH | HWH International Inc. | P - Open-market purchase | 250.0K | $2.00 | $500K |
| 2026-04-02 | HWH | HWH International Inc. | S - Open-market sale | 100.4K | $0.98 | $99K |
| 2025-12-01 | HWH | HWH International Inc. | A - Grant or award | 1.00M | - | |
| 2025-09-12 | AEI | Alset Inc. | S - Open-market sale | 500.0K | $2.67 | $1.34M |
| 2025-08-28 | DSS | DSS, INC. | S - Open-market sale | 130.7K | $1.35 | $176K |
| 2025-08-19 | AEI | Alset Inc. | P - Open-market purchase | 33.0K | $1.29 | $43K |
| 2025-07-23 | AEI | Alset Inc. | J - Other acquisition / disposition | 27.67M | - | |
| 2025-06-30 | AEI | Alset Inc. | A - Grant or award | 280.0K | - | |
| 2025-04-15 | AEI | Alset Inc. | A - Grant or award | 1.00M | - | |
| 2025-04-03 | IBO | IMPACT BIOMEDICAL INC. | S - Open-market sale | 351.6K | $0.49 | $174K |
| 2025-04-02 | IBO | IMPACT BIOMEDICAL INC. | S - Open-market sale | 180.0K | $0.96 | $173K |
| 2025-04-02 | IBO | IMPACT BIOMEDICAL INC. | S - Open-market sale | 273.3K | $0.78 | $213K |
| 2025-04-02 | IBO | IMPACT BIOMEDICAL INC. | S - Open-market sale | 351.6K | $0.58 | $204K |
| 2025-04-02 | IBO | IMPACT BIOMEDICAL INC. | S - Open-market sale | 382.4K | $0.58 | $223K |
| 2025-04-02 | IBO | IMPACT BIOMEDICAL INC. | S - Open-market sale | 2.3K | $0.67 | $2K |
| 2025-04-02 | IBO | IMPACT BIOMEDICAL INC. | S - Open-market sale | 200.0K | $0.67 | $135K |
| 2025-04-02 | IBO | IMPACT BIOMEDICAL INC. | S - Open-market sale | 300.0K | $0.58 | $174K |
| 2025-03-31 | IBO | IMPACT BIOMEDICAL INC. | S - Open-market sale | 1.18M | $1.08 | $1.27M |
| 2025-03-31 | IBO | IMPACT BIOMEDICAL INC. | S - Open-market sale | 650.0K | $1.45 | $941K |
| 2025-03-31 | IBO | IMPACT BIOMEDICAL INC. | S - Open-market sale | 400.0K | $0.98 | $393K |
Companies - Last 90 Days
- DSS, INC. (DSS) - 1 filing, last 2026-07-09
- HWH International Inc. (HWH) - 1 filing, last 2026-06-09
Most Active Insiders Right Now
Heng Fai Ambrose Chan has no recent co-filers at the same companies, so here are the insiders with the largest open-market activity across the market in the last 90 days.
- MetLife Investment Management, LLC - $1600000.00B of FINS open-market activity in the last 90 days
- Magnetar Financial LLC - $16357.48B of CRWV open-market activity in the last 90 days
- Marianne Okland - $18.46B of STNG open-market activity in the last 90 days
- VisionWave Holdings, Inc. - $14.13B of SVRE open-market activity in the last 90 days
- Vanessa Allen Sutherland - $7.44B of PSX open-market activity in the last 90 days
- AI Alpine (Luxembourg) S.a.r.l. - $2.69B of INIO open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Jeffrey Robert Hernandez
- Patrick J. Heron
- Michael Ho
- David Henry Hoffmann
- Gregg R. Honigblum
- HORIZON KINETICS ASSET MANAGEMENT LLC
- HRT FINANCIAL LP
- HRTG GPE, LLC
Frequently Asked Questions
Who is Heng Fai Ambrose Chan?
Heng Fai Ambrose Chan holds the role of Director at DSS, INC. (DSS). Chan's filing history also covers HWH International Inc. (HWH) and SHARING SERVICES GLOBAL Corp (SHRG). Chan has reported 26 insider filings with the SEC since 2024. The most recent filing was in July 2026.…
How many SEC Form 4 filings has Heng Fai Ambrose Chan submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Heng Fai Ambrose Chan been buying or selling stock?
Recorded transactions: 15 open-market purchases ($5.13M) and 15 open-market sales ($5.82M) across all tracked filings.
How accurate is Heng Fai Ambrose Chan's historical track record?
Across 6 tracked purchases, Heng Fai Ambrose Chan averaged +11.3% avg 30-day return with a 17% 30-day win rate. InsiderAlpha rates the track record at 2/5 stars.
Where can I see all of Heng Fai Ambrose Chan's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Heng Fai Ambrose Chan profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.